BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hegazy SK, Tharwat S, Hassan AH. Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients. World J Clin Cases 2023; 11(26): 6105-6121 [PMID: 37731581 DOI: 10.12998/wjcc.v11.i26.6105]
URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6105.htm
Number Citing Articles
1
Sahar K. Hegazy, Ahmed H. Hassan. The effect of combination treatment with casirivimab and imdevimab versus standard antiviral therapy on clinical outcomes in hospitalized COVID-19 patientsDiscover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00045-3
2
Review on Favipiravir Application Uses and Adverse Effect During Covid-19International Journal of Newgen Research in Pharmacy & Healthcare 2023; : 174 doi: 10.61554/ijnrph.v1i2.2023.43
3
Matthew R. Freidel, Roger S. Armen. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of SpikeViruses 2024; 16(5): 712 doi: 10.3390/v16050712